SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Unichem Laboratories informs about scrutinizers report

30 Mar 2026 Evaluate
Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Unichem Laboratories has enclosed the result of remote e-voting in the prescribed format along with Scrutinizer's consolidated report for the following resolutions which were proposed for the approval of the Members through Postal Ballot: a. Appointment of Dr. (Ms) Swati Patankar (DIN 06594600) as a Non-Executive Independent Director for a term of five years with effect from 5th February 2026; b. Material related party transaction(s) between Ipca Laboratories, holding company of Unichem Laboratories and Unichem Pharmaceuticals USA Inc. (Unichem USA), wholly owned subsidiary of Unichem; c. Material related party transaction(s) with Unichem USA, wholly owned subsidiary of Unichem. The resolutions as proposed in the postal ballot notice have been passed by the shareholders by remote e-voting process with requisite majority and are deemed to be passed on the last date of the remote e-voting period i.e. Friday, 27th March 2026. The said results and the scrutinizer’s report will be available on the Company’s website i.e. www.unichemlabs.com and that of the exchanges namely www.bseindia.com and www.nseindia.com and the website of the e-voting agency i.e. https://www.evoting.nsdl.com.

The above information is a part of company’s filings submitted to BSE.

Unichem Lab Share Price

347.80 2.80 (0.81%)
21-Apr-2026 10:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.50
Dr. Reddys Lab 1223.85
Cipla 1231.90
Zydus Lifesciences 932.25
Lupin 2327.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×